Chronic lymphocytic leukemia in the elderly: clinico-biological features, outcomes, and proposal of a prognostic model - Wikidata - wikimedia - TriplyDB

Chronic lymphocytic leukemia in the elderly: clinico-biological features, outcomes, and proposal of a prognostic model

Chronic lymphocytic leukemia in the elderly: clinico-biological features, outcomes, and proposal of a prognostic model

http://www.wikidata.org/entity/Q34272532

about

Management of Chronic Lymphocytic Leukemia in the Elderly Management of elderly and unfit patients with chronic lymphocytic leukemia.Pharmacotherapeutic Management of Chronic Lymphocytic Leukaemia in Patients with Comorbidities: New Agents, New Hope.Idelalisib for the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma.Mechanisms of Resistance to Targeted Therapies in Chronic Lymphocytic Leukemia.Evaluation of geriatric assessment in patients with chronic lymphocytic leukemia: Results of the CLL9 trial of the German CLL study group.Analysis of criteria for treatment initiation in patients with progressive chronic lymphocytic leukemia.Management of chronic lymphocytic leukemia (CLL) in the elderly: a position paper from an international Society of Geriatric Oncology (SIOG) Task Force.NOTCH1 Aberrations in Chronic Lymphocytic Leukemia.CD49d (ITGA4) expression is a predictor of time to first treatment in patients with chronic lymphocytic leukaemia and mutatedIGHVstatus

P2860

Q26775983-F2F58727-A31D-433C-8E7F-285CDEBC32C1 Q30243914-D28DCB63-3460-47ED-A91E-2E667A70DF6E Q38601727-0F57FFB5-24D4-47BF-BB14-E06651E05FB4 Q38850667-96214FF1-E8DB-4F22-B2AF-F1775F0F1370 Q39169789-94CEB710-B57F-41E1-8087-67B34E8FD47E Q41351036-945A4FC0-1FEA-4462-A209-AF0CC167480B Q48231905-17639907-6C7E-4252-8586-F96AA9BAA426 Q48751476-58658153-5587-45CF-817C-2C09BD699E95 Q55668973-39D425F8-7D1D-4BAB-909A-1F7B4112BE42 Q57786905-E843B6CA-5124-4C4F-9C5D-7931963145FA

P2860

Chronic lymphocytic leukemia in the elderly: clinico-biological features, outcomes, and proposal of a prognostic model

http://www.wikidata.org/entity/Q34272532

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Chronic lymphocytic leukemia i ...... proposal of a prognostic model

@ast

Chronic lymphocytic leukemia i ...... proposal of a prognostic model

@en

Chronic lymphocytic leukemia i ...... proposal of a prognostic model

@nl

type

label

Chronic lymphocytic leukemia i ...... proposal of a prognostic model

@ast

Chronic lymphocytic leukemia i ...... proposal of a prognostic model

@en

Chronic lymphocytic leukemia i ...... proposal of a prognostic model

@nl

prefLabel

Chronic lymphocytic leukemia i ...... proposal of a prognostic model

@ast

Chronic lymphocytic leukemia i ...... proposal of a prognostic model

@en

Chronic lymphocytic leukemia i ...... proposal of a prognostic model

@nl

P1433

Q34272532-C2B05747-C1A7-444F-BD1C-6FE83EC2AE76

P1476

Q34272532-335925F4-2E39-4FD9-9A74-22084CE30114

P2093

Q34272532-14240374-5C4A-4A8B-902D-4C17D3EC65DD

Q34272532-157F643C-E8C9-4ECC-A289-E26B348AB5B6

Q34272532-2DB1F506-E96D-4D51-A1C1-A6CCBCB09E4B

Q34272532-40DB99F7-246D-4147-8128-3C4427ED8B77

Q34272532-4B75B5F9-164B-41A6-8404-B5F48815DCCE

Q34272532-550A1382-A63B-436D-BE3A-6EBF9E536EC0

Q34272532-DFE75F8D-E98C-4FD4-9B16-8F7144D6769B

Q34272532-E8D1EEEA-68AE-4771-9698-DF81AEE72C06

Q34272532-EDC72635-3722-4CF7-9FA1-ECE60F023E91

P2860

Q34272532-0498F11B-1A80-4F6A-9E46-27CF377FA8C2

Q34272532-0BC624A4-2185-4A78-9FE4-E1F5E9E1AC76

Q34272532-0C79E8F4-C88F-4854-974D-12A565166751

Q34272532-114DD4BC-1A56-4A33-B38A-8BDA3DDD8244

Q34272532-14A3185E-EDA9-4DE0-A046-1E52C8738CB2

Q34272532-2DD16AA3-9100-4524-94C9-A051DBAC8E2E

Q34272532-35C87212-68E3-4FD3-B13D-44F28263640E

Q34272532-3BE16744-44F1-4A6C-B473-9CF2694492B5

Q34272532-425CAEF9-85A2-43AF-A846-6AEE015344B8

Q34272532-4F01B117-AA30-4AC6-B361-A1285B6CD3FC

P304

Q34272532-97C2252F-B607-45BD-A151-DA385F8F1BAA

P31

Q34272532-7082C76A-44D6-43F8-9B9A-2F932357AB65

P356

Q34272532-D97A2FC2-3916-493D-9652-A960425612C1

P433

Q34272532-28763FFF-69C3-4A97-8AFD-56D1A86D40D0

P478

Q34272532-BB128995-7E77-4E5D-BBA1-72B25CECE323

P50

Q34272532-1E7D170B-B882-48CA-ACC3-5CB18F952961

Q34272532-46197C73-DD3B-49F7-9383-32BDF8127F88

Q34272532-9BFB47A4-F6C4-4E63-AD38-749B38410C24

Q34272532-C749D540-66E7-420D-8DEF-938FEBE1D287

Q34272532-EB59D376-9EFE-4020-8828-612338D0E4FF

P577

Q34272532-71904D86-404D-40EC-84D9-E2017F1357B0

P5875

Q34272532-DE67D96F-7581-438B-8BB2-6A5C7964354F

P698

Q34272532-27667E62-79F9-45B3-9717-79AB50D6DEC2

P921

Q34272532-20087A95-56F7-4453-A3C1-FC2D81C8259C

Q34272532-6E671EEC-6D80-4075-AADC-C9F3D514B359

P932

Q34272532-E6D94CF3-3843-4816-BA42-AC0716E58CC3

P356

HAEMATOL.2014.107326

P1433

P1476

Chronic lymphocytic leukemia i ...... proposal of a prognostic model

@en

P2093

Alejandra Martínez-Trillos

http://www.w3.org/2001/XMLSchema#string

Arturo Pereira

http://www.w3.org/2001/XMLSchema#string

Cristina Royo

http://www.w3.org/2001/XMLSchema#string

Emili Montserrat

http://www.w3.org/2001/XMLSchema#string

Magda Pinyol

http://www.w3.org/2001/XMLSchema#string

Marta Aymerich

http://www.w3.org/2001/XMLSchema#string

Neus Villamor

http://www.w3.org/2001/XMLSchema#string

Rodrigo Santacruz

http://www.w3.org/2001/XMLSchema#string

Tycho Baumann

http://www.w3.org/2001/XMLSchema#string

P2860

Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia

Idelalisib and rituximab in relapsed chronic lymphocytic leukemia

Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia

Bendamustine in combination with rituximab for previously untreated patients with chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group.

Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial

Chronic lymphocytic leukemia in young (≤ 55 years) patients: a comprehensive analysis of prognostic factors and outcomes

Interactions between comorbidity and treatment of chronic lymphocytic leukemia: results of German Chronic Lymphocytic Leukemia Study Group trials.

Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL.

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial.

P304

1599-1604

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.2014.107326

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-06-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263514384

http://www.w3.org/2001/XMLSchema#string

P698

24972773

http://www.w3.org/2001/XMLSchema#string

P921

P932

4181256

http://www.w3.org/2001/XMLSchema#string